Vital Signs (VITL) Beats Q2 View By A Penny
Vital Signs (Nasdaq: VITL) reports Q2 EPS of $0.73, 1 cent better than the analyst estimate of $0.72. Revenues for the quarter were $60.6 million, versus the consensus of $59.04 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
